Connect with us

Life Sciences

Call for papers: JMIR Bioinformatics and Biotechnology

JMIR Bioinformatics and Biotechnology (JBB) is a leading, international, peer-reviewed journal that aims to publish high-quality original research articles,…

Published

on

This article was originally published by BioEngineering

JMIR Bioinformatics and Biotechnology (JBB) is a leading, international, peer-reviewed journal that aims to publish high-quality original research articles, reviews, and perspectives on all aspects of bioinformatics, computational biology, and biotechnology. 

Call for Papers: JMIR Bioinformatics and Biotechnology

Credit: JMIR Publications

JMIR Bioinformatics and Biotechnology (JBB) is a leading, international, peer-reviewed journal that aims to publish high-quality original research articles, reviews, and perspectives on all aspects of bioinformatics, computational biology, and biotechnology. 

We invite researchers, educators, and practitioners to submit their original research articles, reviews, and perspectives to JBB. Our scope includes but is not limited to:

  • Bioinformatics, including genomic variation detection algorithms, tools, and databases
  • Artificial intelligence (AI) applications in genomics and pathology informatics, including “Generative AI”
  • Mathematical modeling in biological systems, including drug delivery and discovery
  • Genomic data visualization
  • Network biology
  • Structural biology and molecular modeling
  • Drug discovery and development
  • Microbial genomics and metagenomics
  • Cancer genomic data analysis

JBB will support the development of new bioinformatics analysis tools, novel algorithms, advanced AI-based predictive models, and network biology studies. We would like to foster not only basic science and algorithm development but also translational research studies in the focus areas listed above. We will also explore the use of new technologies for drug discovery and therapy development in cancer and other complex disorders.

We welcome submissions from researchers, educators, and practitioners from around the world. 

Please visit our website for more information on submission guidelines and the peer-review process.

 

###

 

About JMIR Publications

JMIR Publications is a leading, born-digital, open access publisher of 30+ academic journals and other innovative scientific communication products that focus on the intersection of health, and technology. Its flagship journal, the Journal of Medical Internet Research, is the leading digital health journal globally in content breadth and visibility, and is the largest journal in the medical informatics field.

To learn more about JMIR Publications, please visit jmirpublications.com or connect with us via Twitter, LinkedIn, YouTube, Facebook, and Instagram.

Head office: 130 Queens Quay East, Unit 1100, Toronto, ON, M5A 0P6 Canada

Media contact: communications@jmir.org

The content of this communication is licensed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, published by JMIR Publications, is properly cited.



drug delivery


digital health
artificial intelligence

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Markets

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending